Advanced Urothelial Cancer clinical trials

Explore recruiting advanced urothelial cancer clinical trials.

Recruiting advanced urothelial cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Urothelial Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PROSPECTIVE EVALUATION OF THE DDR GENES ALTERATION TO PREDICT RESPONSE TO PLATINUM-BASED CHEMOTHERAPY IN ADVANCED UROTHELIAL CANCER

Italy

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations

France, Spain, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

CHemotherapy And Sequential ImmunoTherapy for locally advanced urothelial cancer: the CHASIT study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 1/1b Study of RNDO-564 in Participants with Advanced Urothelial Cancer

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 1b-2 Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Various Regimens of Erdafitinib in Subjects with Metastatic or Locally Advanced Urothelial Cancer

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

DISCUS: A Randomised Phase II Study Comparing 3 vs 6 Cycles of Platinum-based Chemotherapy Prior to Maintenance Avelumab in Advanced Urothelial Cancer

Spain, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Advanced Urothelial Cancer trials by city

Advanced Urothelial Cancer clinical trials

Recruiting advanced urothelial cancer studies right now

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors

A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma

Intervention of Bladder Cancer by CAR-T

Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors